Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Tirzepatide Once Weekly for the Treatment of Obesity | New England Journal of Medicine Note: the FDA considers body composition metrics to be safety endpoints which often results in underpowered secondary endpoints in Phase 3 registration trials
By promoting insulin secretion, inhibiting glucagon release, slowing gastric emptying, and increasing satiety, semaglutide helps improve glycemic control (blood sugar levels) in individuals with type 2 diabetes
Theyre meant to be used, along with lifestyle changes such as diet and exercise, under a health care providers supervision
Unfortunately, there is no one-size-fits-all answer
Formulary tier Check your BCBS formulary list (list of covered drugs) to find out if Zepbound is covered as a preferred drug
US$ 24.12
US$ 25.43
US$ 21.88
US$ 21.29
US$ 26.74
US$ 20.21
US$ 23.28
US$ 21.69
